FDA Webview
X
about-us-banner

FDA Related News

Home / Articles / FDA Related News
latest-news-card-1
Human Drugs

FDA Approves Incytes Niktimvo

FDA approves Incytes Niktimvo for some adult and pediatric host-versus-graft treatments.

latest-news-card-1
Human Drugs

Workshop on Measuring Gonadal Toxicity

FDA and the American Society of Clinical Oncology announce a 10/1 joint workshop entitled Measuring Toxicity in Reproductive Organs During Oncology Dr...

latest-news-card-1
Medical Devices

Big Healths SleepioRx Cleared for Sleep Help

FDA clears a Big Health 510(k) for its SleepioRx, a digital therapeutic intended for treating chronic insomnia/insomnia disorder as an adjunct to usua...

latest-news-card-1
Federal Register

Comments Sought on Scheduling for 8 Drugs

Federal Register notice: FDA seeks comments on the abuse potential, medical usefulness, trafficking, and impact of scheduling changes for eight drug s...

latest-news-card-1
Federal Register

Science Board Meeting on Alternative Methods

Federal Register notice: FDA announces a 10/7 Science Board Advisory Committee meeting that will hear an update from the new Alternative Methods Subco...

latest-news-card-1
Human Drugs

Changes Sought in REMS Logic Guidance

Two stakeholders call on FDA to make major changes to a draft guidance on the REMS logic model that is intended to link program design with assessment...

latest-news-card-1
Human Drugs

Prednisolone Solution Needs Stability Studies: Petition

The drug development consulting firm Rahaa asks FDA to require stability studies under refrigerated conditions for generic versions of prednisolone op...

latest-news-card-1
Federal Register

Peripheral/CNS Drugs Panel Renewed

Federal Register notice: FDA renews for two years its Peripheral and Central Nervous System Drugs advisory committee.

latest-news-card-1
Biologics

Galderma BLA for Nemluvio Approved

FDA approves a Galderma BLA for Nemluvio (nemolizumab), a pre-filled pen for subcutaneous injection for adults with prurigo nodularis.